XTX Topco’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $119K | Sell |
13,078
-28,973
| -69% | -$264K | ﹤0.01% | 1843 |
|
|
2025
Q1 | $334K | Buy |
+42,051
| New | +$334K | 0.02% | 1320 |
|
|
2024
Q3 | – | Sell |
-48,249
| Closed | -$524K | – | 2531 |
|
|
2024
Q2 | $524K | Buy |
+48,249
| New | +$524K | 0.04% | 636 |
|
|
2023
Q4 | – | Sell |
-38,093
| Closed | -$784K | – | 2059 |
|
|
2023
Q3 | $784K | Buy |
38,093
+31,258
| +457% | +$643K | 0.13% | 181 |
|
|
2023
Q2 | $321K | Buy |
6,835
+1,847
| +37% | +$86.8K | 0.06% | 670 |
|
|
2023
Q1 | $209K | Buy |
+4,988
| New | +$209K | 0.04% | 928 |
|
|
2021
Q4 | – | Sell |
-5,991
| Closed | -$265K | – | 963 |
|
|
2021
Q3 | $265K | Buy |
5,991
+228
| +4% | +$10.1K | 0.09% | 384 |
|
|
2021
Q2 | $327K | Buy |
+5,763
| New | +$327K | 0.11% | 330 |
|